Maxim Mayer-Cesiano
Maxim Mayer-Cesiano is a corporate attorney focusing primarily on mergers and acquisitions in strategic and private equity transactions. He has represented public and private clients from North America, South America, Europe, Asia and Australia in acquisitions, dispositions, joint ventures, restructurings and financings.

Bio

Mr. Mayer-Cesiano’s practice includes significant work in the consumer products and pharmaceutical sectors, among others. He also has counseled several investment banking clients on advisory matters in M&A transactions. In addition, he has advised companies on takeover preparedness, securities law and corporate governance matters.

Examples of Mr. Mayer-Cesiano’s representations include:

  • JAB Holding Company in a variety of transactions, including its pending acquisition of Panera Bread Company, its acquisitions of Caribou Coffee Company, D.E Master Blenders 1753, Einstein Noah Restaurant Group and Krispy Kreme Doughnuts, and the combination of D.E Master Blenders 1753 and the coffee business of Mondel─ôz International;
  • Lanxess AG in its acquisition of Chemtura Corporation;
  • Becton, Dickinson & Company in the formation of its global respiratory business joint venture with Apax Partners;
  • Coty in its Reverse Morris Trust combination with the fine fragrances, color cosmetics and hair color businesses of The Proctor & Gamble Company;
  • Endo International in a variety of transactions, including its sale of the American Medical Systems male urology portfolio, its acquisition of Indevus Pharmaceuticals and its terminated acquisition of NuPathe;
  • Merck KGaA, Darmstadt, Germany, in a variety of transactions, including its acquisition of Sigma-Aldrich Corporation and the sale of its Crop BioScience business to Novozymes;
  • Jos. A. Bank Clothiers in its unsolicited, but subsequently agreed upon, acquisition by The Men’s Warehouse, as well as its terminated acquisition of the parent company of the Eddie Bauer brand;
  • Anheuser-Busch InBev in its acquisition of the remaining stake of Grupo Modelo that it did not previously own;
  • Miraca Life Sciences in its acquisition of PLUS Diagnostics;
  • PensionDanmark in its 50 percent equity investment in an affiliate of E.On that owns and operates wind farms in Pennsylvania and Texas;
  • Shionogi & Co. in its sale and licensing of the rights to HIV treatments it developed with ViiV Healthcare (a joint venture between GlaxoSmithKline and Pfizer) in return for a 10 percent stake in ViiV and royalties on the worldwide sales of such treatments;
  • Wasserstein & Co. in its acquisition of High Pressure Equipment Company;
  • Valeant Pharmaceuticals International in a variety of transactions, including acquisitions of product lines from Sanofi and Johnson & Johnson;
  • Fortress Investment Group in its sale of Iroko Holdings;
  • Cliffstar Corporation in its sale to Cott Corporation; and
  • Sentinel Data Centers in the sale of its data center business to Digital Realty Trust and its joint venture with Kelso & Co.

Mr. Mayer-Cesiano is involved actively in Skadden’s training and summer associate programs. He serves on the firm’s Associates Committee and provides pro bono legal services to asylum applicants, senior citizens and nonprofit organizations in the arts.

Credentials

Education

  • J.D., University of Pennsylvania Law School, 2006
  • Certificate of Business and Public Policy, Wharton School of the University of Pennsylvania, 2006
  • B.A., Columbia University, Columbia College, 2003

Admissions

  • New York

Maxim Mayer-Cesiano